Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Dual and multi-drug delivery nanoparticles towards neuronal survival and synaptic repair.

Angelova A, Angelov B.

Neural Regen Res. 2017 Jun;12(6):886-889. doi: 10.4103/1673-5374.208546. Review.

2.

BDNF-induced local protein synthesis and synaptic plasticity.

Leal G, Comprido D, Duarte CB.

Neuropharmacology. 2014 Jan;76 Pt C:639-56. doi: 10.1016/j.neuropharm.2013.04.005. Epub 2013 Apr 16. Review.

PMID:
23602987
3.
5.

BDNF mechanisms in late LTP formation: A synthesis and breakdown.

Panja D, Bramham CR.

Neuropharmacology. 2014 Jan;76 Pt C:664-76. doi: 10.1016/j.neuropharm.2013.06.024. Epub 2013 Jul 2. Review.

PMID:
23831365
7.

Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB.

Dekeyster E, Geeraerts E, Buyens T, Van den Haute C, Baekelandt V, De Groef L, Salinas-Navarro M, Moons L.

PLoS One. 2015 Nov 11;10(11):e0142067. doi: 10.1371/journal.pone.0142067. eCollection 2015.

8.

Reduced neuroplasticity in aged rats: a role for the neurotrophin brain-derived neurotrophic factor.

Calabrese F, Guidotti G, Racagni G, Riva MA.

Neurobiol Aging. 2013 Dec;34(12):2768-76. doi: 10.1016/j.neurobiolaging.2013.06.014. Epub 2013 Jul 17.

PMID:
23870838
10.

The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice.

Li N, Liu GT.

Acta Pharmacol Sin. 2010 Mar;31(3):265-72. doi: 10.1038/aps.2010.3. Epub 2010 Feb 15.

11.
12.

Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor.

Viviani B, Bartesaghi S, Corsini E, Villa P, Ghezzi P, Garau A, Galli CL, Marinovich M.

J Neurochem. 2005 Apr;93(2):412-21.

13.

From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF).

Géral C, Angelova A, Lesieur S.

Pharmaceutics. 2013 Feb 8;5(1):127-67. doi: 10.3390/pharmaceutics5010127.

14.

Motoneuron BDNF/TrkB signaling enhances functional recovery after cervical spinal cord injury.

Mantilla CB, Gransee HM, Zhan WZ, Sieck GC.

Exp Neurol. 2013 Sep;247:101-9. doi: 10.1016/j.expneurol.2013.04.002. Epub 2013 Apr 10.

15.

The VGF-derived peptide TLQP62 produces antidepressant-like effects in mice via the BDNF/TrkB/CREB signaling pathway.

Lin P, Wang C, Xu B, Gao S, Guo J, Zhao X, Huang H, Zhang J, Chen X, Wang Q, Zhou W.

Pharmacol Biochem Behav. 2014 May;120:140-8. doi: 10.1016/j.pbb.2014.03.003. Epub 2014 Mar 11.

PMID:
24631486
16.

Dysregulation of BDNF-TrkB signaling in developing hippocampal neurons by Pb(2+): implications for an environmental basis of neurodevelopmental disorders.

Stansfield KH, Pilsner JR, Lu Q, Wright RO, Guilarte TR.

Toxicol Sci. 2012 May;127(1):277-95. doi: 10.1093/toxsci/kfs090. Epub 2012 Feb 17.

17.

Target identification for CNS diseases by transcriptional profiling.

Altar CA, Vawter MP, Ginsberg SD.

Neuropsychopharmacology. 2009 Jan;34(1):18-54. doi: 10.1038/npp.2008.172. Epub 2008 Oct 15. Review.

18.

Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study.

Pilakka-Kanthikeel S, Atluri VS, Sagar V, Saxena SK, Nair M.

PLoS One. 2013 Apr 30;8(4):e62241. doi: 10.1371/journal.pone.0062241. Print 2013.

19.

Cooperation between BDNF and glutamate in the regulation of synaptic transmission and neuronal development.

Martin JL, Finsterwald C.

Commun Integr Biol. 2011 Jan;4(1):14-6. doi: 10.4161/cib.4.1.13761.

20.

Brain-derived neurotrophic factor as a drug target for CNS disorders.

Pezet S, Malcangio M.

Expert Opin Ther Targets. 2004 Oct;8(5):391-9. Review.

PMID:
15469390

Supplemental Content

Support Center